Chemistry and Mechanism of Action — MCQs
Mechanism of action of d-tubocurarine is:
Which of the following nerve fibre types is least susceptible to LA blockade?
What is the preferred concentration range of lidocaine for topical anesthesia?
Which local anesthetic has the highest protein binding capacity?
Which anaesthetic belongs to the ester group?
In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?
What is the mechanism of action of local anesthetics?
Percentage of adrenaline with lignocaine for local infiltration is?
Which of the following is NOT a mechanism of action of theophylline in bronchial asthma?
Which of the following describes the mechanism of action of acarbose?
Chemistry and Mechanism of Action Indian Medical PG Practice Questions and MCQs
Question 1: Mechanism of action of d-tubocurarine is:
- A. Competitive, nondepolarizing block at the Nm cholinergic receptor (Correct Answer)
- B. Noncompetitive, depolarizing block at the Nm cholinergic receptor
- C. Non-competitive, nondepolarizing block at the Nm cholinergic receptor
- D. Competitive, depolarizing block at the Nm cholinergic receptor
Explanation: ***Competitive, nondepolarizing block at the Nm cholinergic receptor*** - **d-tubocurarine** acts as a **competitive antagonist** at the **nicotinic muscle (Nm) cholinergic receptors** on the motor endplate. - It competes with **acetylcholine (ACh)** for binding sites, preventing ACh from activating the receptor and causing **muscle paralysis** without depolarization. *Noncompetitive, depolarizing block at the Nm cholinergic receptor* - This describes the mechanism of action of **depolarizing neuromuscular blockers** like **succinylcholine**, which first *depolarize* the motor endplate before causing paralysis. - d-tubocurarine does not cause initial depolarization; it directly blocks the receptor. *Non-competitive, nondepolarizing block at the Nm cholinergic receptor* - While d-tubocurarine is **nondepolarizing**, it is a **competitive antagonist**, not a non-competitive one. - A non-competitive block would involve binding to a different site on the receptor or an associated ion channel, altering receptor function indirectly. *Competitive, depolarizing block at the Nm cholinergic receptor* - This option incorrectly combines the concepts, as **depolarizing blockers** like succinylcholine act initially by **depolarizing** the endplate, whereas d-tubocurarine is purely a **nondepolarizing** agent. - The "competitive" aspect would be true for the binding of ACh to its site on a depolarizing agent, but the effect of d-tubocurarine is simply to block, not depolarize.
Question 2: Which of the following nerve fibre types is least susceptible to LA blockade?
- A. B fibers
- B. A beta
- C. C fibers
- D. A alpha (Correct Answer)
Explanation: **A alpha** - **A alpha fibers** are the **largest** and most heavily myelinated nerve fibers, responsible for **motor function** and **proprioception**. - Due to their large diameter and thick myelination, they have the **highest conduction velocity** and are the **least susceptible to local anesthetic blockade**, requiring higher concentrations or longer exposure times. *B fibers* - **B fibers** are **preganglionic autonomic fibers** that are myelinated but of relatively small diameter. - They are generally **highly sensitive to local anesthetics**, often being blocked even before A-delta and C fibers, due to their specific physiologic properties like repetitive firing and length of node of Ranvier. *C fibers* - **C fibers** are **unmyelinated** and have the **smallest diameter**, transmitting **pain, temperature, and autonomic information**. - Despite being unmyelinated, their small diameter makes them **highly sensitive to local anesthetics**, as the drug can easily penetrate to block sodium channels. *A beta* - **A beta fibers** are large, myelinated fibers involved in transmitting **touch and pressure sensations**. - While myelinated, they are **smaller than A-alpha fibers** and thus more susceptible to local anesthetic blockade than A-alpha, but less so than C or B fibers.
Question 3: What is the preferred concentration range of lidocaine for topical anesthesia?
- A. 2-4% (Correct Answer)
- B. 7-12%
- C. 12-15%
- D. <2%
Explanation: ***Correct Option: 2-4%*** - **Lidocaine** is an **amide-type local anesthetic** commonly used for topical anesthesia to numb localized areas before minor procedures. - The **preferred concentration range for topical application is 2-4%**, which provides effective anesthesia with an acceptable safety profile. - **2% lidocaine gel/cream** is commonly used for skin and genital mucosa. - **4% lidocaine** is standard for oral and respiratory mucous membranes. - **5% lidocaine patches** are used for post-herpetic neuralgia. - This concentration range balances **clinical efficacy** with **minimal systemic toxicity risk**. *Incorrect Option: <2%* - Concentrations below **2%** are generally **suboptimal** for achieving significant topical anesthesia. - These lower concentrations result in **insufficient pain relief** or require longer application times. - While 0.5-1% solutions exist, they are primarily used for infiltration anesthesia, not topical application. *Incorrect Option: 7-12%* - Concentrations in the **7-12%** range are **too high** for routine topical use and increase the risk of **systemic toxicity**. - These concentrations are not standard in clinical practice for general topical anesthesia. - Higher concentrations increase absorption without proportional improvement in efficacy. *Incorrect Option: 12-15%* - Concentrations in the **12-15%** range are **excessively high** and pose substantial **risk of systemic absorption and toxicity**. - Such high concentrations are **not recommended** for topical anesthesia in clinical practice. - Even 10% sprays (used for oropharyngeal anesthesia) require strict dose limitations to prevent toxicity.
Question 4: Which local anesthetic has the highest protein binding capacity?
- A. Tetracaine (Correct Answer)
- B. Procaine
- C. Lidocaine
- D. Prilocaine
Explanation: ***Tetracaine*** - **Tetracaine** has a very high protein binding capacity (around 80%), which correlates with its **long duration of action** and high potency. - High protein binding means less free drug is available to reach nerve membranes immediately, but it also provides a reservoir for sustained release, contributing to its prolonged anesthetic effect. *Lidocaine* - **Lidocaine** has an intermediate protein binding capacity (around 60-70%), making it a **medium-duration** local anesthetic. - Its protein binding is lower than tetracaine, hence it has a shorter clinical duration of action compared to tetracaine. *Prilocaine* - **Prilocaine** has a relatively low protein binding capacity (around 55%), leading to a **shorter duration of action** compared to lidocaine and tetracaine. - Its lower protein binding also contributes to its relatively lower potency. *Procaine* - **Procaine** has the lowest protein binding capacity among the listed options (around 5-10%), making it a **short-acting** local anesthetic. - Its rapid metabolism by plasma pseudocholinesterases further contributes to its limited duration of action.
Question 5: Which anaesthetic belongs to the ester group?
- A. Lignocaine
- B. Propofol
- C. Procaine (Correct Answer)
- D. Benzocaine
Explanation: ***Procaine*** - **Procaine** is a classical **ester-type** local anesthetic, characterized by an ester linkage between the aromatic and amine parts of its chemical structure. - Ester-type local anesthetics are metabolized by **plasma pseudocholinesterase**, leading to a shorter duration of action compared to amides. *Benzocaine* - **Benzocaine** is also an ester local anesthetic, but it is typically used topically due to its poor water solubility and absorption. - While an ester, the question implies a common injectable agent, making procaine a more representative answer for the "ester group" in general anesthetic use. *Lignocaine* - **Lignocaine** (also known as lidocaine) is an **amide-type** local anesthetic, which can be identified by an amide linkage in its chemical structure. - Amide local anesthetics are primarily metabolized in the **liver** and generally have a longer duration of action than esters. *Propofol* - **Propofol** is a **short-acting intravenous general anesthetic** and is not classified as a local anesthetic or belonging to the ester group. - It works by potentiation of **GABA-A receptors** and is used for induction and maintenance of general anesthesia.
Question 6: In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?
- A. Procaine
- B. Cocaine
- C. Prilocaine (Correct Answer)
- D. Tetracaine
Explanation: **Local anesthetics are classified into two chemical groups: esters (aminoesters) and amides. Allergies to esters typically do not cross-react with amides.** ***Prilocaine*** - **Prilocaine** is an **amide-type local anesthetic**, and allergies to **aminoesters** typically do not cross-react with **amides**. - It is a safe alternative in patients with a known allergy to **ester-type local anesthetics**. *Cocaine* - **Cocaine** is an **ester-type local anesthetic**, sharing a similar chemical structure with **aminoesters**. - Patients allergic to **aminoesters** are likely to experience a **cross-reaction** with **cocaine**. *Procaine* - **Procaine** is a classic **ester-type local anesthetic** (an aminoester). - An allergy to aminoesters directly implies an allergy to **procaine** due to its chemical classification. *Tetracaine* - **Tetracaine** is also an **ester-type local anesthetic** (an aminoester). - It is contraindicated in patients with an allergy to **aminoesters** due to the high risk of **allergic reaction**.
Question 7: What is the mechanism of action of local anesthetics?
- A. Block chloride channels
- B. Block calcium channels
- C. Block sodium channels (Correct Answer)
- D. Block potassium channels
Explanation: ***Block sodium channels*** - Local anesthetics work by **reversibly binding** to the alpha subunit of **voltage-gated sodium channels** on the neuronal membrane. - This binding prevents the influx of sodium ions, thereby inhibiting the **depolarization** of the neuron and **propagation of action potentials**. *Block chloride channels* - **Chloride channels** are primarily involved in **hyperpolarization** or stabilization of the resting membrane potential, and their blockade is not the primary mechanism of local anesthesia. - Drugs like **benzodiazepines** modulate GABA-gated chloride channels for their anxiolytic and sedative effects. *Block calcium channels* - **Calcium channels** are important for neurotransmitter release and muscle contraction, but their blockade is not the way local anesthetics exert their effects. - **Calcium channel blockers** are used in cardiovascular medicine (e.g., diltiazem, verapamil) to reduce heart rate and blood pressure. *Block potassium channels* - **Potassium channels** are crucial for repolarization of the neuronal membrane and maintaining the resting potential. - While some toxins block potassium channels, it is not the principal mechanism by which **local anesthetics** achieve their nerve blocking effect.
Question 8: Percentage of adrenaline with lignocaine for local infiltration is?
- A. 1:1000
- B. 1:10000
- C. 1:50000 (Correct Answer)
- D. 1:200000
Explanation: ***1:50000*** - This concentration of **adrenaline (epinephrine)** is commonly used with **lignocaine (lidocaine)** for local infiltration to prolong the anesthetic effect and reduce bleeding. - At this concentration, adrenaline acts as a **vasoconstrictor**, decreasing systemic absorption of lignocaine and allowing a higher dose locally. *1:1000* - This concentration of adrenaline is typically used for the treatment of **anaphylaxis** and is considered too high for local infiltration with lignocaine. - Using such a high concentration locally can lead to severe **vasoconstriction**, tissue ischemia, and systemic side effects like **tachycardia** and **hypertension**. *1:10000* - This concentration is too strong for routine local infiltration and is usually reserved for **cardiac arrest** protocols or severe anaphylaxis when administered intravenously. - It would carry a significant risk of **tissue damage** and systemic effects if used for local infiltration. *1:200000* - While sometimes used, **1:50000** is generally the more common and effective concentration for achieving **hemostasis** and prolonging anesthesia during local infiltration. - A 1:200000 concentration provides a lesser degree of **vasoconstriction**, potentially leading to less prolonged local anesthetic effect and reduced bleeding control compared to 1:50000.
Question 9: Which of the following is NOT a mechanism of action of theophylline in bronchial asthma?
- A. Adenosine receptor antagonism
- B. Increased histone deacetylation
- C. Phosphodiesterase inhibition
- D. Beta-2 receptor stimulation (Correct Answer)
Explanation: ***Beta-2 receptor stimulation*** - Theophylline is a **non-selective phosphodiesterase inhibitor** and an **adenosine receptor antagonist**, but it does not directly stimulate beta-2 receptors. - **Beta-2 receptor agonists** like salbutamol or formoterol are the medications that work by stimulating these receptors to cause bronchodilation. *Phosphodiesterase inhibition* - Theophylline inhibits **phosphodiesterase enzymes**, leading to an increase in intracellular **cAMP** levels. - This increase in **cAMP** promotes bronchodilation by relaxing airway smooth muscle. *Adenosine receptor antagonism* - Theophylline acts as an antagonist at **adenosine receptors**, particularly A1 and A2B. - Antagonism of adenosine receptors can reduce bronchoconstriction and inflammatory mediator release, contributing to its anti-asthmatic effects. *Increased histone deacetylation* - Theophylline, particularly at lower concentrations, increases the activity of **histone deacetylase (HDAC)**. - This action helps to **repress inflammatory gene expression**, which is a unique anti-inflammatory mechanism separate from its bronchodilatory effects.
Question 10: Which of the following describes the mechanism of action of acarbose?
- A. It reduces post prandial hyperglycemia
- B. It decreases the progression of impaired tolerance to overt diabetes mellitus
- C. It can cause hypoglycemia
- D. It acts by inhibiting the enzyme alpha-glucosidase (Correct Answer)
Explanation: ***It acts by inhibiting the enzyme alpha-glucosidase*** - **Acarbose** is an **alpha-glucosidase inhibitor**, which means it blocks the action of enzymes located in the brush border of the small intestine. - This inhibition delays the digestion of **complex carbohydrates** into absorbable monosaccharides, thereby slowing glucose absorption. *It reduces post prandial hyperglycemia* - While **acarbose** does reduce **postprandial hyperglycemia**, this is a **clinical effect** of the drug rather than its fundamental mechanism of action. - The reduction in blood glucose occurs *because* of its inhibitory action on alpha-glucosidase, not as the primary mechanism itself. *It decreases the progression of impaired tolerance to overt diabetes mellitus* - This is an observed **long-term benefit** of acarbose use, particularly in individuals with impaired glucose tolerance, but it is not its **direct pharmacological mechanism**. - This effect results from the sustained improvement in glucose control, reducing the stress on pancreatic beta cells. *It can cause hypoglycemia* - **Acarbose** alone generally **does not cause hypoglycemia** because its action is localized to the gut, delaying carbohydrate absorption rather than increasing insulin secretion or glucose uptake. - However, hypoglycemia can occur if acarbose is taken in combination with other anti-diabetic medications that *do* increase insulin levels (e.g., sulfonylureas or insulin).
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free